10.03.2026

Alithea Bio: Featured in smartXhealth Startup Spotlight

ALITHEA BIO SMARTX

Alithea Bio: AI Meets Immunotherapy

Startup Spotlight: smartXhealth Newsletter

Alithea Biotechnology GmbH

We develop data-driven solutions for modern immunotherapies. By combining Immunopeptidomics, Mass Spectrometry, and AI-based Bioinformatics, we identify therapeutic targets with high precision.

Our cloud-based HLA-peptide database helps predict the efficacy and safety of new therapies early, reducing preclinical risks and shortening development cycles.

Alithea Bio Team

Trinationale Innovationskraft

Featured by smartXhealth and supported by BadenCampus, we are proud to represent the Freiburg start-up scene.

The recent BioCampus Upper Rhine Investor Day in Basel highlighted the growing importance of our trinationale innovation space. Explore the BioCampus Platform for more details.

Join us for smartXhealth connect in May 2026.


Contact smartXhealth Today

Read more

Alithea Bio Welcomes Associate Professor Pouya Faridi to its Scientific Advisory Board

Read
World of Vaccine Congress Alithea Bio

Meet Alithea Bio at World Vaccine Congress Europe 2026

Read
Alithea Bio

Alithea Bio Featured in Nature Biotechnology’s Dark Proteome Report

Read